Celcuity said its Phase 3 clinical trial evaluating gedatolisib resulted in positive topline results. The clinical-stage biotechnology company's trial evaluated gedatolisib plus fulvestrant with and ...

Ethiopia’s state-owned Ethio Telecom reported that its annual pretax profit shot up by more than 80% year-on-year to $550 ...

The S&P 500 and the Nasdaq Composite ended Thursday's session with fresh record closes after scoring new all-time intraday ...

The American chip-making giant is facing a strategic crossroads as it chases rivals like Nvidia and TSMC in the global silicon boom. UnitedHealth Confirms Civil and Criminal Justice Department Probes ...

Net income at the US' largest power provider by market cap nearly doubled in the second quarter, driven by surging data ...

Bapcor crashes on earnings miss: Automotive parts group plunged 28% to $3.65 after flagging weaker-than-expected May and June ...

Bloomberg was allowed, and the New York Times wasn't. Anthropic said it had no knowledge of the list and that its contractor, ...

Dow Jones gains on strong healthcare and financials while Nasdaq drops as tech stocks retreat, signaling sector rotation in ...

The nearest resistance level for Dow Jones is located in the 44,600 – 44,700 range. A successful test of this level will open ...

Financials (-1.65%) were the worst performers again, on further bank weakness; Commonwealth Bank plunged 3.1% in its biggest ...